Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report

被引：4

作者：

Remo, Mylene ^{[1
]}

Abraham, Ivy ^{[1
]}

Kankanala, Vineel ^{[2
]}

Chacra, Wadih ^{[2
]}

Danciu, Oana C. ^{[1
]}

机构：

[1] Univ Illinois, Coll Med, Div Hematol Oncol, 840 South Wood St,Room 832,MC 713, Chicago, IL 60612 USA

[2] Univ Illinois, Coll Med, Div Gastroenterol & Hepatol, Chicago, IL USA

来源：

ANTICANCER RESEARCH | 2017年 / 37卷 / 07期

关键词：

Breast cancer; chemotherapy; hepatitis B; liver failure; screening; VIRUS REACTIVATION; MANAGEMENT; PREVENTION;

D O I：

10.21873/anticanres.11755

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hepatitis B virus (HBV) reactivation is a known complication of immunosuppressive therapy. While patients who are undergoing treatment with anti-CD20 agents or stem cell transplantation are commonly screened for chronic HBV infection prior to treatment, there are no consensus guidelines regarding HBV screening for patients undergoing chemotherapy for solid tumors. We present a rare case of fulminant liver failure due to HBV reactivation in a patient receiving chemotherapy for breast cancer. Our case highlights the importance of developing definitive guidelines regarding HBV screening in patients receiving chemotherapy for solid tumors and raises the question of the need for universal screening.

引用

页码：3791 / 3793

页数：3

共 50 条

[31] Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: Role of lamivudine prophylaxis
Coiffier, Bertrand
CANCER INVESTIGATION, 2006, 24 (05) : 548 - 552
[32] Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate
Yamauchi, Ryo
Takeyama, Yasuaki
Takata, Kazuhide
Fukunaga, Atsushi
Sakurai, Kunitoshi
Tanaka, Takashi
Fukuda, Hiromi
Fukuda, Sho
Kunimoto, Hideo
Umeda, Kaoru
Morihara, Daisuke
Yokoyama, Keiji
Irie, Makoto
Shakado, Satoshi
Sakisaka, Shotaro
Hirai, Fumihito
INTERNAL MEDICINE, 2020, 59 (09) : 1163 - 1166
[33] Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management
Liu, Chun-Jen
Chen, Pei-Jer
Chen, Ding-Shinn
Kao, Jia-Horng
HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 316 - 326
[34] Clinical Profile and Efficacy of Antivirals in Hepatitis B Virus Reactivation, in Patients With Cancer Receiving Chemotherapy
Wani, Manzoor A.
Sodhi, Jaswinder S.
Yatoo, Ghulam N.
Shah, Altaf
Geelani, Sajad
Zargar, Showkat A.
Gulzar, Ghulam M.
Khan, Mushtaq
Aziz, Sheikh A.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (06) : 590 - 598
[35] Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management
Lubel, John S.
Angus, Peter W.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (05) : 864 - 871
[36] Evidence of reactivation of hepatitis B virus in patients receiving chemotherapy for malignancies
Ikeda, Masafumi
Takahashi, Hideaki
Hashimoto, Yusuke
Ohno, Izumi
Mitsunaga, Shuichi
Umemoto, Kumiko
Watanabe, Kazuo
Okusaka, Takuji
ANNALS OF ONCOLOGY, 2016, 27
[37] Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature
Teplinsky, Eleonora
Cheung, Derrick
Weisberg, Ilan
Jacobs, Ramon E. A.
Wolff, Martin
Park, James
Friedman, Kent
Muggia, Franco
Jhaveri, Komal
BREAST CANCER RESEARCH AND TREATMENT, 2013, 141 (02) : 167 - 172
[38] Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature
Eleonora Teplinsky
Derrick Cheung
Ilan Weisberg
Ramon E. A. Jacobs
Martin Wolff
James Park
Kent Friedman
Franco Muggia
Komal Jhaveri
Breast Cancer Research and Treatment, 2013, 141 : 167 - 172
[39] Reactivation of hepatitis B virus infection in pancreatic cancer:: a case report
Öksüzoglu, B
Kiliçkap, S
Yalcin, S
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (12) : 543 - 545
[40] TemozolomideFirst report of reactivation of hepatitis B: case report
Reactions Weekly, 2007, 1149 (1) : 24 - 24

← 1 2 3 4 5 →